Pharmacogenetic analysis of genes implicated in rodent models of antidepressant response: association of TREK1 and treatment resistance in the STAR(*)D study (Q28269390)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Pharmacogenetic analysis of genes implicated in rodent models of antidepressant response: association of TREK1 and treatment resistance in the STAR(*)D study	scientific article

Statements

scholarly article

0 references

Pharmacogenetic analysis of genes implicated in rodent models of antidepressant response: association of TREK1 and treatment resistance in the STAR(*)D study (English)

0 references

6

0 references

4

0 references

Jordan W Smoller

8

object named as

Jordan W Smoller

0 references

Augustus John Rush

7

object named as

A John Rush

0 references

Madhukar Trivedi

5

object named as

Madhukar H Trivedi

0 references

1

object named as

Roy H Perlis

0 references

Jesen Fagerness

3

object named as

Jesen Fagerness

0 references

author name string

Priya Moorjani

2

0 references

language of work or name

0 references

publication date

November 2008

0 references

Neuropsychopharmacology

0 references

33

0 references

2810-9

0 references

12

0 references

Efficiency and power in genetic association studies

1 reference

https://api.crossref.org/works/10.1038/NPP.2008.6

21 April 2017

The neuronal background K2P channels: focus on TREK1

1 reference

https://api.crossref.org/works/10.1038/NPP.2008.6

21 April 2017

Inhibition of the human two-pore domain potassium channel, TREK-1, by fluoxetine and its metabolite norfluoxetine

1 reference

https://api.crossref.org/works/10.1038/NPP.2008.6

21 April 2017

Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment

1 reference

https://api.crossref.org/works/10.1038/NPP.2008.6

21 April 2017

Sequential phosphorylation mediates receptor- and kinase-induced inhibition of TREK-1 background potassium channels

1 reference

https://api.crossref.org/works/10.1038/NPP.2008.6

21 April 2017

PLINK: a tool set for whole-genome association and population-based linkage analyses

1 reference

https://api.crossref.org/works/10.1038/NPP.2008.6

21 April 2017

Alterations in 5-HT1B receptor function by p11 in depression-like states

1 reference

https://api.crossref.org/works/10.1038/NPP.2008.6

21 April 2017

Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

21 April 2017

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

21 April 2017

Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

21 April 2017

High-throughput development and characterization of a genomewide collection of gene-based single nucleotide polymorphism markers by chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

21 January 2018

Pharmacogenomic evaluation of the antidepressant citalopram in the mouse tail suspension test.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

21 January 2018

Diagnosis and definition of treatment-resistant depression

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

21 January 2018

Definition and epidemiology of treatment-resistant depression

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

21 January 2018

Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

21 January 2018

Strengthening clinical effectiveness trials: equipoise-stratified randomization.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

21 January 2018

PIP2 hydrolysis underlies agonist-induced inhibition and regulates voltage gating of two-pore domain K+ channels.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

21 January 2018

Pharmacogenetics of psychotropic drug response

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

21 January 2018

Pharmacogenetics of antidepressant medication intolerance

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

21 January 2018

The future of association studies: gene-based analysis and replication

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

21 January 2018

Set association analysis of SNP case-control and microarray data

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

21 January 2018

Association between treatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D study.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

21 January 2018

An evaluation of the quick inventory of depressive symptomatology and the hamilton rating scale for depression: a sequenced treatment alternatives to relieve depression trial report.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

21 January 2018

Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

21 January 2018

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

21 January 2018

Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

21 January 2018

How do antidepressants work? Prospects for genetic analysis of drug mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

21 January 2018

Pooling pharmacogenetic studies on the serotonin transporter: a mega-analysis.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

21 January 2018

Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

21 January 2018

Spurious genetic associations.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

21 January 2018

Outcome definitions and predictors in depression.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

21 January 2018

Medication augmentation after the failure of SSRIs for depression.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

21 January 2018

The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

21 January 2018

Placebo response in studies of major depression: variable, substantial, and growing

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

21 January 2018

The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

21 January 2018

Cloning, functional expression and brain localization of a novel unconventional outward rectifier K+ channel

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

7 January 2021

based on heuristic

inferred from DOI database lookup

TREKing toward new antidepressants

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

7 January 2021

based on heuristic

inferred from DOI database lookup

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

7 January 2021

based on heuristic

inferred from DOI database lookup

Deletion of the background potassium channel TREK-1 results in a depression-resistant phenotype

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

7 January 2021

based on heuristic

inferred from DOI database lookup

The Inventory of Depressive Symptomatology (IDS): psychometric properties.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

7 January 2021

based on heuristic

inferred from DOI database lookup

Cns distribution of members of the two-pore-domain (KCNK) potassium channel family.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/NPP.2008.6

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Dimensions Publication ID

0 references

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

ResearchGate publication ID

0 references

Springer Nature article ID

10.1038/npp.2008.6

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28269390&oldid=1959106039"